Ridgewood Investments’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-168
Closed -$16.2K 718
2024
Q3
$16.2K Sell
168
-6
-3% -$585 0.01% 445
2024
Q2
$16K Buy
+174
New +$16.1K 0.01% 459
2023
Q3
Sell
-174
Closed -$15.9K 204
2023
Q2
$15.9K Hold
174
0.01% 468
2023
Q1
$12.8K Buy
+174
New +$15.1K 0.01% 495

Other funds holding AMED

Ridgewood Investments's AMED Position: Q4 2024 in Review

Ridgewood Investments sold out of Amedisys (AMED) in Q4 2024, closing a stake of 168 shares — an estimated $16.2K sold.

Ridgewood Investments first reported a position in AMED in Q1 2023 and held it in 4 quarters. The position peaked at $16.2K in Q3 2024. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • Ridgewood Investments reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • Ridgewood Investments sold 168 Amedisys shares in Q4 2024, an estimated $16.2K.
  • Ridgewood Investments first reported a position in Amedisys in Q1 2023 and held it in 4 quarters.
  • Ridgewood Investments's Amedisys position peaked at $16.2K in Q3 2024.
  • 290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Ridgewood Investments's 13F filing for Q4 2024, filed 10 Jan 2025.